Real-world data on the Oxford-AstraZeneca and Pfizer-BioNTech vaccines in protecting against death and hospitalisation from COVID-19
Real-world data on the Oxford-AstraZeneca and Pfizer-BioNTech vaccines in protecting against death and hospitalisation from COVID-19
This explainer is more than 90 days old. Some of the information might be out of date or no longer relevant. Browse our homepage for up to date content or request information about a specific topic from our team of scientists.
This article has been translated from its original language. Please reach out if you have any feedback on the translation.
Two preprints, unpublished non-peer reviewed studies, by Public Health England (PHE), look at the effectiveness of the Oxford-AstraZeneca and Pfizer-BioNTech COVID-19 vaccines in protecting against death and hospitalisation from COVID-19.
Two preprints, unpublished non-peer reviewed studies, by Public Health England (PHE), look at the effectiveness of the Oxford-AstraZeneca and Pfizer-BioNTech COVID-19 vaccines in protecting against death and hospitalisation from COVID-19.
Publication
‘Effectiveness of BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on mortality following COVID-19’
Not peer-reviewed
Peer-reviewed
Effectiveness of BNT162b2 mRNA and ChAdOx1 adenovirus vector COVID-19 vaccines on risk of hospitalisation among older adults in England: an observational study using surveillance data
Not peer-reviewed
Peer-reviewed
What our experts say
Context and background
Resources
Expert Comments:
Prof Jonathan Ball
These real world data confirm that COVID-19 vaccines are protecting the vast majority of people from serious disease and death, especially after two doses. This is an incredible outcome as it paves a way out of this, and future, lockdowns.
To realise the full benefits, we need to get as many people vaccinated as possible. Then, when this has been achieved we should move towards good surveillance and monitoring vaccine effectiveness instead of relying on isolation and other restrictive measures, as we learn to live with the virus.
